Mid Cap
In Vitro & In Vivo Diagnostic Substances
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price | Price change % | |
|---|---|---|---|---|---|
 1 Lantheus LNTH $7.59B | $7.59B | $109.27 | +1.08% | ||
 2 Neogen NEOG $3.22B | $3.22B | $14.85 | +1.09% | ||
 3 QuidelOrtho QDEL $2.87B | $2.87B | $42.74 | +1.38% | ||
 4 Myriad Genetics MYGN $2.21B | $2.21B | $24.37 | -6.12% |